openPR Logo
Press release

Anticonvulsants Market Overview, Growth And Forecast 2024-2033

11-26-2024 02:50 PM CET | Health & Medicine

Press release from: The Business research company

Anticonvulsants Market Overview

Anticonvulsants Market Overview

The Business Research Company recently released a comprehensive report on the Global Anticonvulsants Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

According to The Business Research Company's, The anticonvulsants market size has grown steadily in recent years. It will grow from $18.39 billion in 2023 to $19.08 billion in 2024 at a compound annual growth rate (CAGR) of 3.7%. The growth in the historic period can be attributed to risen prevalence of epilepsy, advancements in diagnostic capabilities, expanding indications, focus on personalized medicine, increased awareness and education.

The anticonvulsants market size is expected to see steady growth in the next few years. It will grow to $21.75 billion in 2028 at a compound annual growth rate (CAGR) of 3.3%. The growth in the forecast period can be attributed to continuing increase in epilepsy cases, expanding applications in neuropsychiatry, development of new anticonvulsant agents, increasing emphasis on mental health, global health initiatives. Major trends in the forecast period include pediatric applications and formulations, shift towards extended-release formulations, growing adoption of generic versions, integration with digital health solutions, research on neuroprotective effects.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/anticonvulsants-global-market-report

Market Drivers and Trends:

The rise in the prevalence of epilepsy is expected to propel the growth of the anticonvulsants market going forward. Epilepsy is a common disorder that affects the brain and frequently results in seizures. It is a chronic nontransmissible disease of the brain that affects people of all ages. Anticonvulsants are medications used to suppress seizures in people with epilepsy. Anticonvulsants help control symptoms of epilepsy by blocking the abnormal electrical activity in the brain that causes seizures and is not necessarily a cure for the disease. For instance, in February 2023, according to the World Health Organization, a Switzerland-based United Nations agency responsible for public health, globally, an estimated 5 million people are diagnosed with epilepsy yearly. The high-income countries have an estimated 49 per 0.1 million people are diagnosed with epilepsy each year, and as many as 139 per 0.1 million in low- and middle-income countries. Therefore, the rise in the prevalence of epilepsy is driving the growth of the anticonvulsants market going forward.

Product development is a key trend gaining popularity in the anticonvulsants market. Major companies operating in the anticonvulsants market are focused on developing innovative products to strengthen their position and gain a competitive advantage. For instance, in December 2022, Lupin Limited, an India-based pharmaceutical company, launched an abbreviated new drug application, Rufinamide tablets USP, 200 mg and 400 mg, an anticonvulsant drug. Rufinamide is used with other medications to control seizures in people who have a severe form of epilepsy called Lennox-Gastaut syndrome, which begins during childhood and causes several types of seizures, behavioral disturbances, and developmental delays in an individual.

Key Benefits for Stakeholders:

• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=10682&type=smp

Major Key Players of the Market:

Eisai Co Ltd.; GlaxoSmithKline plc; Pfizer Inc.; Johnson & Johnson Services Inc .; Novartis AG; Jazz Pharmaceuticals Inc.; UCB SA; Teva Pharmaceutical Industries Ltd.; Sunovion Pharmaceuticals Inc.; Sanofi SA; Zydus Lifesciences Ltd.; Lupin Limited; Ratiopharm Group; Kannalife Inc.; Neuropathix Inc.; AbbVie Inc.; Sun Pharmaceutical Industries Ltd.; Cipla Limited; Mylan N.V.; Aurobindo Pharma Limited; Dr. Reddy's Laboratories Ltd.; Torrent Pharmaceuticals Ltd.; Hikma Pharmaceuticals plc; AstraZeneca plc; Glenmark Pharmaceuticals Limited; Laurus Labs Limited; Biocon Limited; Recordati S.p.A.; Neurocrine Biosciences Inc.

Anticonvulsants Market 2024 Key Insights:

• The anticonvulsants market size will grow to $21.75 billion in 2028 at a compound annual growth rate (CAGR) of 3.3%.
• The Surge In Epilepsy Cases Drives Growth In The Anticonvulsants Market
• Innovative Product Development Drives Advancements In The Anticonvulsants Market
• North America was the largest region in the Anticonvulsants market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=10682&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anticonvulsants Market Overview, Growth And Forecast 2024-2033 here

News-ID: 3757122 • Views:

More Releases from The Business research company

Leading Companies Fueling Growth and Innovation in the Liquid Crystal Polymers Market
Leading Companies Fueling Growth and Innovation in the Liquid Crystal Polymers M …
The liquid crystal polymers market is poised for significant expansion in the coming years, driven by rising demand across multiple high-tech sectors. As industries increasingly adopt these advanced materials for their superior properties, the market outlook appears robust. Let's explore the market's size predictions, key players, emerging trends, and detailed segmentation to understand the future trajectory of liquid crystal polymers. Forecasted Expansion of the Liquid Crystal Polymers Market by 2030
Leather Chemicals Market Overview: Major Segments, Strategic Developments, and Leading Companies
Leather Chemicals Market Overview: Major Segments, Strategic Developments, and L …
The leather chemicals industry is set for significant growth as it adapts to evolving environmental standards and increasing demand within related markets. With sustainability and efficiency becoming key priorities, innovations and strategic collaborations are paving the way for new advancements. Below is an in-depth examination of the projected market size, leading companies, emerging trends, and detailed segment analysis shaping the future of leather chemicals. Expected Market Size and Growth Outlook for
Analysis of Segments and Major Growth Areas in the Isopropyl Alcohol Market
Analysis of Segments and Major Growth Areas in the Isopropyl Alcohol Market
The isopropyl alcohol market is positioned for significant expansion as demand continues to grow across various sectors. Increasing investments in healthcare, rising sanitation needs, and the expansion of specialty chemical manufacturing are some of the key factors driving market growth. Let's explore the market valuation, leading players, emerging trends, and segment details that define this evolving industry. Expected Growth Trajectory of the Isopropyl Alcohol Market The isopropyl alcohol market is
Key Strategic Developments and Emerging Changes Shaping the Inorganic Pigments Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Inorganic Pigments M …
The inorganic pigments market is poised for significant expansion as industries increasingly seek sustainable and high-performance coloring solutions. With a growing emphasis on eco-friendly products and advanced applications, this market is set to evolve considerably by 2030. Let's explore the market size projections, leading companies, emerging trends, and key segments shaping the inorganic pigments landscape. Projected Growth Trajectory of the Inorganic Pigments Market The inorganic pigments market is expected to

All 5 Releases


More Releases for Anticonvulsants

Key Trends Reshaping the Anticonvulsants Market: Innovative Product Development …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Anticonvulsants Market Size Growth Forecast: What to Expect by 2025? The growth of the anticonvulsants market has been consistent in the past years, rising from $18.85 billion in 2024 to $19.25 billion in 2025 with a Compound Annual Growth Rate (CAGR) of 2.1%. This historical growth is the result
Key Trends Reshaping the Anticonvulsants Market: Innovative Product Development …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Anticonvulsants Market Size Growth Forecast: What to Expect by 2025? The growth of the anticonvulsants market has been consistent in the past years, rising from $18.85 billion in 2024 to $19.25 billion in 2025 with a Compound Annual Growth Rate (CAGR) of 2.1%. This historical growth is the result
The Surge In Epilepsy Cases Drives Growth In The Anticonvulsants Market: Key Fac …
The Anticonvulsants Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Anticonvulsants Market Size During the Forecast Period? The Anticonvulsants Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial
CAGR Growth and New Market Options: The Anticonvulsants Market Exploration
The advancing anticonvulsants market showcases steady growth and promising new opportunities as market giants focus on innovation and investment. What Is The Projected Market Size Of The Global Anticonvulsants Market And Its Growth Rate? • The anticonvulsants market experienced steady growth in recent years, increasing from $18.85 billion in 2024 to $19.44 billion in 2025 at a compound annual growth rate (CAGR) of 3.1%. • The market size is projected to continue this
Anticonvulsants Market Therapeutic Survey Reviews, Analysis 2025
The report titled “Anticonvulsants Market” report will be very useful to get a stronger and effective business outlook. It provides an in-depth analysis of different attributes of industries such as trends, SWOT analysis, policies, and clients operating in several regions. The qualitative and quantitative analysis techniques have been used by analysts to provide accurate and applicable data to the readers, business owners and industry experts. The Anticonvulsants market was valued at
Generic and branded anticonvulsants are restraining the growth of novel therapie …
Anticonvulsants, also commonly known as antiepileptic drugs or antiseizure drugs are a diverse group of pharmacology agents used in the treatment of epileptic seizures. Epilepsy is a chronic disorder resulting in repeated and unprovoked seizures. Epileptic seizures are commonly referred as convulsions. Anticonvulsants are mainly used for treatment of epileptic seizures. Epileptic seizures are caused by disturbance in the electrical activity of the brain. In addition, anticonvulsants are also used